108 results
DEFA14A
EDIT
Editas Medicine, Inc.
16 Apr 24
Additional proxy soliciting materials
4:30pm
))
Definitive Proxy Statement
Definitive Additional Materials
Soliciting Material Pursuant to §240.14a-12
EDITAS MEDICINE, INC.
(Name of registrant … ):
No fee required.
Fee paid previously with preliminary materials.
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.
S-3ASR
EX-1.2
EDIT
Editas Medicine, Inc.
28 Feb 24
Automatic shelf registration
5:13pm
counsel.
(k) No Suspension. Trading in the Common Stock shall not have been suspended on Nasdaq.
(l) Other Materials. On each date on which
S-3ASR
1yjiltr0l1w5h
28 Feb 24
Automatic shelf registration
5:13pm
424B5
7we6q1 r5ty8n
15 Jun 23
Prospectus supplement for primary offering
4:22pm
424B5
qcrl8eh1x1df
14 Jun 23
Prospectus supplement for primary offering
5:20pm
DEFA14A
klf8q6wxquqpimkn
18 Apr 23
Additional proxy soliciting materials
4:31pm